期刊文献+

甲状腺癌患者甲状腺球蛋白和肿瘤特异性生长因子表达水平变化及临床意义分析 被引量:2

下载PDF
导出
摘要 目的:研究甲状腺癌患者血清甲状腺球蛋白(Thyroglobulin,Tg)和肿瘤特异性生长因子(Tumor specific growth factor,TSGF)表达水平变化的临床意义。方法:选取本院2016年10月至2019年10月收治的甲状腺癌患者88例作为观察组,另选取50例健康体检者作为对照组。通过生化和免疫法测定患者血清中Tg与TSGF水平,并分析二者表达水平变化与甲状腺癌患者临床病理特征之间的相关性。结果:甲状腺癌患者血清Tg、TSGF水平显著高于正常组(P<0.05);且在性别、年龄、病理分型中Tg表达水平无明显差异(P>0.05),而在肿瘤大小、TNM分期、淋巴结转移中存在明显统计学差异(P<0.05);同时甲状腺患者血清TSGF表达水平在性别、年龄、肿瘤大小、病例分型、TNM分期、淋巴结转移中均未见明显差异(P>0.05);Spearman相关性分析结果显示,患者血清Tg表达水平与肿瘤大小、TNM分期、淋巴结转移呈正相关(r=0.361、0.352、0.378,P<0.05)。结论:Tg表达水平有助于诊断分化型甲状腺癌和用于评估其病情进展,TSGF表达水平可以作为甲状腺癌早期筛查的一种有效指标。
出处 《四川生理科学杂志》 2021年第4期613-615,共3页 Sichuan Journal of Physiological Sciences
  • 相关文献

参考文献9

二级参考文献97

  • 1管昌田.分化型甲状腺癌术后复发和转移的早期诊断及处理[J].国外医学(放射医学核医学分册),1995,19(4):156-161. 被引量:12
  • 2American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated ThyroidCancer, Cooper DS, Doherty GM, et al. Revisedmanagement guidelines for patients with thyroid nodulesand differentiated thyroid cancer[J]. Thyroid, 2009,19(11): 1167-1214.
  • 3Hegedus L. Clinical practice. The thyroid noduIe[J]. NEngl J Med, 2004,351(17): 1764-1771.
  • 4McLeod DS, Watters KF,Carpenter AD, et al.Thyrotropin and thyroid cancer diagnosis: a systematicreview and dose-response meta-analysis[J]. J ClinEndocrinol Metab, 2012,97(8): 2682-2692.
  • 5Costante G, Meringolo D,Durante C, et al. Predictivevalue of serum calcitonin levels for preoperativediagnosis of medullary thyroid carcinoma in a cohort of5817 consecutive patients with thyroid nodules [J]. J ClinEndocrinol Metab, 2007, 92(2): 450-455.
  • 6Moon WJ,Kwag HJ, Na DG Are there any specificultrasound findings of nodular hyperplasia ( ‘leave mealone ’ lesion) to differentiate it from follicular adenoma [J].Acta Radiologica,2009,50(4): 383-388.
  • 7Moon WJ, Jung SL, Lee JH,et al. Benign and malignantthyroid nodules: US differentiation-mnlticenter retrospectivestudy[J]. Radiology, 2008,247(3): 762-770.
  • 8Pacini F, Castagna MG, Brilli L, et al. Thyroid cancer:ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up[J]. Ann Oncol, 2010, 21(SuppI 5):V214-219.
  • 9Boelaert K, Horacek J, Holder RL, et al. Serumthyrotropin concentration as a novel predictor ofmalignancy in thyroid nodules investigated by fine-needleaspiration[J]. J Clin Endo Metab, 2006,91(11):4295-4301.
  • 10Rossi M,Buratto M, Bruni S, et al. Role ofultrasonographic/clinical profile, cytology, and BRAFV600E mutation evaluation in thyroid nodule screeningfor malignancy: a prospective study [J]. J Clin EndocrinolMetab, 2012,97(7): 2354-2361.

共引文献98

同被引文献21

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部